Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanotech Biomachines

Nanotech Biomachines
Out of Business LATEST DEAL TYPE

Developer of sensor technology intended to revolutionize the way 21st-century medicines will be discovered and developed. The company's sensor technology leverages modern electronic materials and simple membrane preparations to achieve sensitivity and specificity using naive biology and is capable of measuring real-time binding to IMP target that is mass-independent, cell-free and label-free, and provides a direct electronic output using native IMPs in fluid membranes, providing clients with sensor technology for therapeutic discovery and development applications.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 2600 Hilltop Drive
  • Building B, Suite C110
  • Richmond, CA 94806
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nanotech Biomachines’s full profile, request a free trial.

Nanotech Biomachines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jun-2019 00000 Completed Out of Business
4. Later Stage VC 01-Jan-2017 00000 Completed Startup
3. Angel (individual) 27-Apr-2015 0000 00000 Completed Startup
2. Accelerator/Incubator 26-Apr-2013 $105K Completed Startup
1. Angel (individual) 23-May-2012 $105K $105K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »